Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

71.32
BATS BZX Real-Time Price
As of 1:28pm ET
 +0.59 / +0.83%
Today’s Change
51.82
Today|||52-Week Range
73.06
+3.68%
Year-to-Date
Ionis Down, Glaxo Dumps IONIS-TTRRx Phase III Study Plans
11:20am / Zacks.com - Paid Partner Content
Cancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases
May 26 / MotleyFool.com - Paid Partner Content
Flexion (FLXN) Zilretta Gets Positive FDA Guidance; Stock Up
8:51am / Zacks.com - Paid Partner Content
Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta
May 25 / Zacks.com - Paid Partner Content
Minerva Surges on Positive Results on Depression Candidate
7:27am / Zacks.com - Paid Partner Content
PDL BioPharma Agrees to Equity Investment in Noden Pharma
May 25 / Zacks.com - Paid Partner Content
Innocoll Stock Gains on Favorable Phase III Data on Xaracoll
May 26 / Zacks.com - Paid Partner Content
AbbVie/Boehringer Report Crohn's Disease Drug Interim Data
May 25 / Zacks.com - Paid Partner Content
Sanofi's Diabetes Drug Combination Wins FDA Panel Backing
May 26 / Zacks.com - Paid Partner Content
Biodel/Albireo Limited to Combine; Focus on Liver Diseases
May 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close70.73
Today’s open70.77
Day’s range70.71 - 71.53
Volume145,467
Average volume (3 months)6,480,722
Market cap$118.9B
Dividend yield2.13%
Data as of 1:28pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+25.44%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+4.29%
P/E ratio75.9
Price/Sales6.97
Price/Book8.29

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.60-1.07%
SNYSanofi+0.00+0.01%
GSKGlaxoSmithKline-0.30-0.70%
ABBVAbbVie+0.82+1.32%
Data as of 2:13pm ET, 05/27/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$0.65
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs